This is an old revision of this page, as edited by BogBot (talk | contribs) at 18:33, 2 September 2011 (populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 18:33, 2 September 2011 by BogBot (talk | contribs) (populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compound | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
IUPAC name
| |
| PubChem CID | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.003.929  |
| Chemical and physical data | |
| Formula | C19H16O5 |
| Molar mass | 324.33 g/mol g·mol |
| (verify) | |
Efloxate is a vasodilator.
| Vasodilators used in cardiac diseases (C01D) | |
|---|---|
| Nitrovasodilators | |
| Quinolone vasodilators | |
| Others | |
| |
 | This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it. |